Skip to content

Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate

C31H38N8O4 — CID 177044038

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate
SMILESCN1CC2CN(c3ncc4c(=O)c(C(=O)NCC5CCCN5C(=O)OC(C)(C)C)c5[nH]c6ccccc6n5c4n3)CC2C1
InChIInChI=1S/C31H38N8O4/c1-31(2,3)43-30(42)38-11-7-8-20(38)12-32-28(41)24-25(40)21-13-33-29(37-16-18-14-36(4)15-19(18)17-37)35-26(21)39-23-10-6-5-9-22(23)34-27(24)39/h5-6,9-10,13,18-20,34H,7-8,11-12,14-17H2,1-4H3,(H,32,41)
InChIKeyXIDRRFPGXWLDCF-UHFFFAOYSA-N
MW586.70 g/mol
LogP2.85
Rot. Bonds4

About Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate

Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate (PubChem CID 177044038) has the molecular formula C31H38N8O4 and a molecular weight of 586.70 g/mol. Its IUPAC name is tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate.

Molecular Properties

Compound NameTert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate
PubChem CID177044038
Molecular FormulaC31H38N8O4
Molecular Weight586.70 g/mol
Exact Mass586.30
IUPAC Nametert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate
SMILESCN1CC2CN(c3ncc4c(=O)c(C(=O)NCC5CCCN5C(=O)OC(C)(C)C)c5[nH]c6ccccc6n5c4n3)CC2C1
InChIInChI=1S/C31H38N8O4/c1-31(2,3)43-30(42)38-11-7-8-20(38)12-32-28(41)24-25(40)21-13-33-29(37-16-18-14-36(4)15-19(18)17-37)35-26(21)39-23-10-6-5-9-22(23)34-27(24)39/h5-6,9-10,13,18-20,34H,7-8,11-12,14-17H2,1-4H3,(H,32,41)
InChIKeyXIDRRFPGXWLDCF-UHFFFAOYSA-N
XLogP2.85
TPSA128.17 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms43
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500586.70
LogP ≤ 52.85
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate?
The IUPAC name of Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate (CID 177044038) is tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate.
What is the SMILES notation for Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate?
The canonical SMILES for Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate is CN1CC2CN(c3ncc4c(=O)c(C(=O)NCC5CCCN5C(=O)OC(C)(C)C)c5[nH]c6ccccc6n5c4n3)CC2C1.
What is the InChIKey of Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate?
The InChIKey is XIDRRFPGXWLDCF-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H38N8O4/c1-31(2,3)43-30(42)38-11-7-8-20(38)12-32-28(41)24-25(40)21-13-33-29(37-16-18-14-36(4)15-19(18)17-37)35-26(21)39-23-10-6-5-9-22(23)34-27(24)39/h5-6,9-10,13,18-20,34H,7-8,11-12,14-17H2,1-4H3,(H,32,41).
What are the key properties of Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate?
Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate has a molecular weight of 586.70 g/mol, XLogP of 2.85, 4 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl 2-[[[4-(2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl)-8-oxo-1,3,5,11-tetrazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carbonyl]amino]methyl]pyrrolidine-1-carboxylate is sourced from PubChem (CID 177044038), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.